Histological protection against ischemia–reperfusion injury by early ischemic preconditioning in rat retina
Brief ischemia was reported to protect various cells against injury induced by subsequent ischemia–reperfusion, and this phenomenon is known as ischemic preconditioning. The aims of the present study were to clarify whether early ischemic preconditioning could be observed in the rat retina by histol...
Gespeichert in:
Veröffentlicht in: | Brain research 2004-07, Vol.1015 (1), p.154-160 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 160 |
---|---|
container_issue | 1 |
container_start_page | 154 |
container_title | Brain research |
container_volume | 1015 |
creator | Sakamoto, Kenji Yonoki, Yuzuru Kuwagata, Mayumi Saito, Maki Nakahara, Tsutomu Ishii, Kunio |
description | Brief ischemia was reported to protect various cells against injury induced by subsequent ischemia–reperfusion, and this phenomenon is known as ischemic preconditioning. The aims of the present study were to clarify whether early ischemic preconditioning could be observed in the rat retina by histological examination. Male Sprague–Dawley rats were subjected to 60 min of retinal ischemia by raising intraocular pressure to 130 mm Hg. Ischemic preconditioning was achieved by applying 5 min of ischemia 5–60 min before 60 min of ischemia. Additional groups of rats received 10 mg/kg 8-phenyltheophiline and 4.5 mg/kg 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), adenosine A
1 receptor antagonists, 5 mg/kg 5-hydroxydecanoate and 1 mg/kg glibenclamide, ATP-sensitive K
+ channel blockers, or 2.5 mg/kg chelerythrine and 0.1 mg/kg bisindolylmaleimide I, protein kinase C inhibitors, 15 or 30 min before preconditioning. In the non-preconditioned group, cell loss in the ganglion cell layer and thinning of the inner plexiform and inner nuclear layer were observed 7 days after 60 min of ischemia. Five minutes of preconditioning ischemia 20–40 min before 60 min of sustained ischemia completely prevented the retinal tissue damage induced by the sustained ischemia. Treatment with 8-phenyltheophylline, DPCPX, 5-hydroxydecanoate, glibenclamide, chelerythrine and bisindolylmaleimide I almost completely reduced the protective effect of early ischemic preconditioning. The results in the present study indicated that early ischemic preconditioning was demonstrated in the rat retina. Stimulation of adenosine receptors, opening of ATP-sensitive K
+ channels and activation of protein kinase C might be involved in the underlying protective mechanisms. |
doi_str_mv | 10.1016/j.brainres.2004.04.074 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66660631</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006899304007206</els_id><sourcerecordid>17851796</sourcerecordid><originalsourceid>FETCH-LOGICAL-c491t-ffc0560278445310e82fbe63525545c1926f10cabd107c341460c9a54639e72a3</originalsourceid><addsrcrecordid>eNqFkc9u1DAQxq0KRJfCK1S5wC3L-E_s-AaqKEWqxAXOluNMtl4lzmI7SHvjHXhDnqSOdiu41RrJsuY3n2fmI-SawpYClR_22y5aHyKmLQMQ2zWUuCAb2ipWSybgBdkAgKxbrfkleZ3Svjw51_CKXNKGMc6V3pDpzqc8j_POOztWhzhndNnPobK7Ip9y5ZN7wMnbv7__RDxgHJa0pn3YL_FYdccKbRyPT5grEujm0PtVxIddAatocxUx-2DfkJeDHRO-Pd9X5Mft5-83d_X9ty9fbz7d105omuthcNBIYKoVouEUsGVDh5I3rGlE46hmcqDgbNdTUI4LKiQ4bRshuUbFLL8i70-6ZaCfC6ZsptIgjqMNOC_JyHJAcvosSFXbUKVlAeUJdHFOKeJgDtFPNh4NBbM6YvbmyRGzOmLWUKIUXp9_WLoJ-39lZwsK8O4M2FQ8GKINzqf_OM21AFa4jycOy-J-eYwmOY_BYe_LyrPpZ_9cL4--_a9_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17851796</pqid></control><display><type>article</type><title>Histological protection against ischemia–reperfusion injury by early ischemic preconditioning in rat retina</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Sakamoto, Kenji ; Yonoki, Yuzuru ; Kuwagata, Mayumi ; Saito, Maki ; Nakahara, Tsutomu ; Ishii, Kunio</creator><creatorcontrib>Sakamoto, Kenji ; Yonoki, Yuzuru ; Kuwagata, Mayumi ; Saito, Maki ; Nakahara, Tsutomu ; Ishii, Kunio</creatorcontrib><description>Brief ischemia was reported to protect various cells against injury induced by subsequent ischemia–reperfusion, and this phenomenon is known as ischemic preconditioning. The aims of the present study were to clarify whether early ischemic preconditioning could be observed in the rat retina by histological examination. Male Sprague–Dawley rats were subjected to 60 min of retinal ischemia by raising intraocular pressure to 130 mm Hg. Ischemic preconditioning was achieved by applying 5 min of ischemia 5–60 min before 60 min of ischemia. Additional groups of rats received 10 mg/kg 8-phenyltheophiline and 4.5 mg/kg 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), adenosine A
1 receptor antagonists, 5 mg/kg 5-hydroxydecanoate and 1 mg/kg glibenclamide, ATP-sensitive K
+ channel blockers, or 2.5 mg/kg chelerythrine and 0.1 mg/kg bisindolylmaleimide I, protein kinase C inhibitors, 15 or 30 min before preconditioning. In the non-preconditioned group, cell loss in the ganglion cell layer and thinning of the inner plexiform and inner nuclear layer were observed 7 days after 60 min of ischemia. Five minutes of preconditioning ischemia 20–40 min before 60 min of sustained ischemia completely prevented the retinal tissue damage induced by the sustained ischemia. Treatment with 8-phenyltheophylline, DPCPX, 5-hydroxydecanoate, glibenclamide, chelerythrine and bisindolylmaleimide I almost completely reduced the protective effect of early ischemic preconditioning. The results in the present study indicated that early ischemic preconditioning was demonstrated in the rat retina. Stimulation of adenosine receptors, opening of ATP-sensitive K
+ channels and activation of protein kinase C might be involved in the underlying protective mechanisms.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/j.brainres.2004.04.074</identifier><identifier>PMID: 15223379</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject>Adenosine receptor ; Adrenergic alpha-Antagonists - pharmacology ; Animals ; Biological and medical sciences ; Enzyme Inhibitors - pharmacology ; Intraocular Pressure - physiology ; Ischemia - pathology ; Ischemic Preconditioning ; K + channel ; Male ; Medical sciences ; Ophthalmology ; Potassium Channel Blockers - pharmacology ; Protein kinase C ; Purinergic P1 Receptor Antagonists ; Rats ; Rats, Sprague-Dawley ; Reperfusion ; Reperfusion Injury - pathology ; Reperfusion Injury - prevention & control ; Retina - drug effects ; Retina - pathology ; Retinal ischemia ; Retinal Vessels ; Retinopathies ; Theophylline - analogs & derivatives ; Theophylline - pharmacology ; Time Factors ; Xanthines - pharmacology</subject><ispartof>Brain research, 2004-07, Vol.1015 (1), p.154-160</ispartof><rights>2004 Elsevier B.V.</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c491t-ffc0560278445310e82fbe63525545c1926f10cabd107c341460c9a54639e72a3</citedby><cites>FETCH-LOGICAL-c491t-ffc0560278445310e82fbe63525545c1926f10cabd107c341460c9a54639e72a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.brainres.2004.04.074$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15939402$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15223379$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sakamoto, Kenji</creatorcontrib><creatorcontrib>Yonoki, Yuzuru</creatorcontrib><creatorcontrib>Kuwagata, Mayumi</creatorcontrib><creatorcontrib>Saito, Maki</creatorcontrib><creatorcontrib>Nakahara, Tsutomu</creatorcontrib><creatorcontrib>Ishii, Kunio</creatorcontrib><title>Histological protection against ischemia–reperfusion injury by early ischemic preconditioning in rat retina</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>Brief ischemia was reported to protect various cells against injury induced by subsequent ischemia–reperfusion, and this phenomenon is known as ischemic preconditioning. The aims of the present study were to clarify whether early ischemic preconditioning could be observed in the rat retina by histological examination. Male Sprague–Dawley rats were subjected to 60 min of retinal ischemia by raising intraocular pressure to 130 mm Hg. Ischemic preconditioning was achieved by applying 5 min of ischemia 5–60 min before 60 min of ischemia. Additional groups of rats received 10 mg/kg 8-phenyltheophiline and 4.5 mg/kg 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), adenosine A
1 receptor antagonists, 5 mg/kg 5-hydroxydecanoate and 1 mg/kg glibenclamide, ATP-sensitive K
+ channel blockers, or 2.5 mg/kg chelerythrine and 0.1 mg/kg bisindolylmaleimide I, protein kinase C inhibitors, 15 or 30 min before preconditioning. In the non-preconditioned group, cell loss in the ganglion cell layer and thinning of the inner plexiform and inner nuclear layer were observed 7 days after 60 min of ischemia. Five minutes of preconditioning ischemia 20–40 min before 60 min of sustained ischemia completely prevented the retinal tissue damage induced by the sustained ischemia. Treatment with 8-phenyltheophylline, DPCPX, 5-hydroxydecanoate, glibenclamide, chelerythrine and bisindolylmaleimide I almost completely reduced the protective effect of early ischemic preconditioning. The results in the present study indicated that early ischemic preconditioning was demonstrated in the rat retina. Stimulation of adenosine receptors, opening of ATP-sensitive K
+ channels and activation of protein kinase C might be involved in the underlying protective mechanisms.</description><subject>Adenosine receptor</subject><subject>Adrenergic alpha-Antagonists - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Intraocular Pressure - physiology</subject><subject>Ischemia - pathology</subject><subject>Ischemic Preconditioning</subject><subject>K + channel</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Ophthalmology</subject><subject>Potassium Channel Blockers - pharmacology</subject><subject>Protein kinase C</subject><subject>Purinergic P1 Receptor Antagonists</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Reperfusion</subject><subject>Reperfusion Injury - pathology</subject><subject>Reperfusion Injury - prevention & control</subject><subject>Retina - drug effects</subject><subject>Retina - pathology</subject><subject>Retinal ischemia</subject><subject>Retinal Vessels</subject><subject>Retinopathies</subject><subject>Theophylline - analogs & derivatives</subject><subject>Theophylline - pharmacology</subject><subject>Time Factors</subject><subject>Xanthines - pharmacology</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9u1DAQxq0KRJfCK1S5wC3L-E_s-AaqKEWqxAXOluNMtl4lzmI7SHvjHXhDnqSOdiu41RrJsuY3n2fmI-SawpYClR_22y5aHyKmLQMQ2zWUuCAb2ipWSybgBdkAgKxbrfkleZ3Svjw51_CKXNKGMc6V3pDpzqc8j_POOztWhzhndNnPobK7Ip9y5ZN7wMnbv7__RDxgHJa0pn3YL_FYdccKbRyPT5grEujm0PtVxIddAatocxUx-2DfkJeDHRO-Pd9X5Mft5-83d_X9ty9fbz7d105omuthcNBIYKoVouEUsGVDh5I3rGlE46hmcqDgbNdTUI4LKiQ4bRshuUbFLL8i70-6ZaCfC6ZsptIgjqMNOC_JyHJAcvosSFXbUKVlAeUJdHFOKeJgDtFPNh4NBbM6YvbmyRGzOmLWUKIUXp9_WLoJ-39lZwsK8O4M2FQ8GKINzqf_OM21AFa4jycOy-J-eYwmOY_BYe_LyrPpZ_9cL4--_a9_</recordid><startdate>20040723</startdate><enddate>20040723</enddate><creator>Sakamoto, Kenji</creator><creator>Yonoki, Yuzuru</creator><creator>Kuwagata, Mayumi</creator><creator>Saito, Maki</creator><creator>Nakahara, Tsutomu</creator><creator>Ishii, Kunio</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20040723</creationdate><title>Histological protection against ischemia–reperfusion injury by early ischemic preconditioning in rat retina</title><author>Sakamoto, Kenji ; Yonoki, Yuzuru ; Kuwagata, Mayumi ; Saito, Maki ; Nakahara, Tsutomu ; Ishii, Kunio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c491t-ffc0560278445310e82fbe63525545c1926f10cabd107c341460c9a54639e72a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adenosine receptor</topic><topic>Adrenergic alpha-Antagonists - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Intraocular Pressure - physiology</topic><topic>Ischemia - pathology</topic><topic>Ischemic Preconditioning</topic><topic>K + channel</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Ophthalmology</topic><topic>Potassium Channel Blockers - pharmacology</topic><topic>Protein kinase C</topic><topic>Purinergic P1 Receptor Antagonists</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Reperfusion</topic><topic>Reperfusion Injury - pathology</topic><topic>Reperfusion Injury - prevention & control</topic><topic>Retina - drug effects</topic><topic>Retina - pathology</topic><topic>Retinal ischemia</topic><topic>Retinal Vessels</topic><topic>Retinopathies</topic><topic>Theophylline - analogs & derivatives</topic><topic>Theophylline - pharmacology</topic><topic>Time Factors</topic><topic>Xanthines - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sakamoto, Kenji</creatorcontrib><creatorcontrib>Yonoki, Yuzuru</creatorcontrib><creatorcontrib>Kuwagata, Mayumi</creatorcontrib><creatorcontrib>Saito, Maki</creatorcontrib><creatorcontrib>Nakahara, Tsutomu</creatorcontrib><creatorcontrib>Ishii, Kunio</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sakamoto, Kenji</au><au>Yonoki, Yuzuru</au><au>Kuwagata, Mayumi</au><au>Saito, Maki</au><au>Nakahara, Tsutomu</au><au>Ishii, Kunio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Histological protection against ischemia–reperfusion injury by early ischemic preconditioning in rat retina</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>2004-07-23</date><risdate>2004</risdate><volume>1015</volume><issue>1</issue><spage>154</spage><epage>160</epage><pages>154-160</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>Brief ischemia was reported to protect various cells against injury induced by subsequent ischemia–reperfusion, and this phenomenon is known as ischemic preconditioning. The aims of the present study were to clarify whether early ischemic preconditioning could be observed in the rat retina by histological examination. Male Sprague–Dawley rats were subjected to 60 min of retinal ischemia by raising intraocular pressure to 130 mm Hg. Ischemic preconditioning was achieved by applying 5 min of ischemia 5–60 min before 60 min of ischemia. Additional groups of rats received 10 mg/kg 8-phenyltheophiline and 4.5 mg/kg 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), adenosine A
1 receptor antagonists, 5 mg/kg 5-hydroxydecanoate and 1 mg/kg glibenclamide, ATP-sensitive K
+ channel blockers, or 2.5 mg/kg chelerythrine and 0.1 mg/kg bisindolylmaleimide I, protein kinase C inhibitors, 15 or 30 min before preconditioning. In the non-preconditioned group, cell loss in the ganglion cell layer and thinning of the inner plexiform and inner nuclear layer were observed 7 days after 60 min of ischemia. Five minutes of preconditioning ischemia 20–40 min before 60 min of sustained ischemia completely prevented the retinal tissue damage induced by the sustained ischemia. Treatment with 8-phenyltheophylline, DPCPX, 5-hydroxydecanoate, glibenclamide, chelerythrine and bisindolylmaleimide I almost completely reduced the protective effect of early ischemic preconditioning. The results in the present study indicated that early ischemic preconditioning was demonstrated in the rat retina. Stimulation of adenosine receptors, opening of ATP-sensitive K
+ channels and activation of protein kinase C might be involved in the underlying protective mechanisms.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier B.V</pub><pmid>15223379</pmid><doi>10.1016/j.brainres.2004.04.074</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-8993 |
ispartof | Brain research, 2004-07, Vol.1015 (1), p.154-160 |
issn | 0006-8993 1872-6240 |
language | eng |
recordid | cdi_proquest_miscellaneous_66660631 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adenosine receptor Adrenergic alpha-Antagonists - pharmacology Animals Biological and medical sciences Enzyme Inhibitors - pharmacology Intraocular Pressure - physiology Ischemia - pathology Ischemic Preconditioning K + channel Male Medical sciences Ophthalmology Potassium Channel Blockers - pharmacology Protein kinase C Purinergic P1 Receptor Antagonists Rats Rats, Sprague-Dawley Reperfusion Reperfusion Injury - pathology Reperfusion Injury - prevention & control Retina - drug effects Retina - pathology Retinal ischemia Retinal Vessels Retinopathies Theophylline - analogs & derivatives Theophylline - pharmacology Time Factors Xanthines - pharmacology |
title | Histological protection against ischemia–reperfusion injury by early ischemic preconditioning in rat retina |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T11%3A54%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Histological%20protection%20against%20ischemia%E2%80%93reperfusion%20injury%20by%20early%20ischemic%20preconditioning%20in%20rat%20retina&rft.jtitle=Brain%20research&rft.au=Sakamoto,%20Kenji&rft.date=2004-07-23&rft.volume=1015&rft.issue=1&rft.spage=154&rft.epage=160&rft.pages=154-160&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/j.brainres.2004.04.074&rft_dat=%3Cproquest_cross%3E17851796%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17851796&rft_id=info:pmid/15223379&rft_els_id=S0006899304007206&rfr_iscdi=true |